Zydus receives final approval for Clonidine Hcl Injection

Zydus receives final approval for Clonidine Hcl Injection     ___________________________________________________________________________   Ahmedabad, 24 February 2014 Zydus Cadila has received the final approval from the USFDA to market Clonidine Hcl Injection 0.1 and 0.5 mg/ml, 10 ml. Clonidine hydrochloride injection is a centrally -acting analgesic solution for use in continuous epidural infusion devices which is indicated in combination with opiates for the treatment of severe pain in cancer patients that is not adequately relieved by opioid analgesics alone. The group now has 90 approvals and has so far filed 216 ANDAs since the commencement of filing process in FY 2003-04. ***

The release as fetched from its publisher. zyduslife.com ↗